| Grant number: | 17/03463-2 |
| Support Opportunities: | Scholarships in Brazil - Scientific Initiation |
| Start date: | April 01, 2017 |
| End date: | March 31, 2018 |
| Field of knowledge: | Biological Sciences - Immunology |
| Principal Investigator: | Gislane Lelis Vilela de Oliveira |
| Grantee: | Guilherme Siqueira Pardo Rodrigues |
| Host Institution: | Faculdade de Ciências da Saúde de Barretos Dr Paulo Prata (FACISB). Barretos , SP, Brazil |
Abstract In humans, over one hundred trillion microorganisms, mainly bacteria, colonize the oral-gastrointestinal tract, and the vast majority of these reside in the distal gut and was termed microbiota. The most important microbiota's contributions for the host include carbohydrates digestion and fermentation, vitamin production, mucosal-associated lymphoid tissues development, immune responses polarization and prevent pathogens colonization. However, when this mutualistic relationship between host and microbiota is interrupted, the intestinal microbiota may cause or contribute to the development of infectious diseases, inflammatory and autoimmune diseases. Therefore, the aim of this study is to evaluate intestinal dysbiosis in patients with rheumatoid arthritis (RA) and to correlate with plasma concentrations of Th1 and Th17 cytokines. Patients and control subjects will be included in the health center from Health Department from Barretos. The study was approved by the Ethics Committee (1269/2016), and patients and controls will sign the informed consent and answer a socio-epidemiological questionnaire. Fecal samples are collected by own individuals or families in universal collectors. Clinical data such as deformities due to tendon rupture and joint erosions, involvement of the cervical spine, extra-articular manifestations, neurological, rheumatoid factor, anti-CCP, erythrocyte sedimentation rate, C-reactive protein, composite indexes of disease activity (ICAD), measures of functional capacity (HAQ) and drug treatment will be recorded. Bacterial DNA is extracted by using commercial kit and the microbiota characterization will be performed by real-time PCR. The quantification of Th1 and Th17 cytokines will be done by ELISA assays. The results of the intestinal microbiota of patients and controls will be analyzed by using Mann-Whitney test and correlations of microbiota results with clinical and cytokines data will be assessed by Spearmans' test. We expect to find differences in the composition of the intestinal microbiota of patients with RA compared with healthy subjects and possible correlations with clinical data and Th1 and Th17 cytokines. Additional studies are necessary, and possibly in the future, immunomodulatory probiotics may aid in the treatment of RA. (AU) | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |